Former FDA Commissioner Scott Gottlieb discusses the "Eris" (EG.5) variant on CNBC, noting its ability to escape prior immunity while remaining less pathogenic than previous strains. Gottlieb emphasizes the importance of wastewater data from BioBot Analytics due to the unreliability of home testing and state reporting. The hosts criticize Gottlieb's ties to Pfizer and the potential for wastewater surveillance to be used for social control.



















